Citation Tools

Download PDFPDF
A phase II trial of intravenous etoposide (VP-16-213) in epithelial ovarian cancer resistant to cisplatin or carboplatin: clinical and serological evidence of activity

Download to a citation manager

Cite this article as:
HOSKINS PJ, McMURTRIE E, SWENERTON KD
A phase II trial of intravenous etoposide (VP-16-213) in epithelial ovarian cancer resistant to cisplatin or carboplatin: clinical and serological evidence of activity